Otsuka Holdings Co., Ltd.: Colitis, Ulcerative trials
The registry lists 10 Colitis, Ulcerative studies with Otsuka Holdings Co., Ltd. as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 2 2Phase 3 4Phase 4 2No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- An Exploratory Study of Rebamipide in Patients With Active Ulcerative ColitisCompletedNCT00463151Phase 2Results posted
- A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative ColitisTerminatedNCT00317356Phase 2Results posted
- Adacolumn in Refractory UC Patients TrialCompletedNCT01481142Phase 4
- ADAPT Adacolumn Pediatric Trial in Ulcerative ColitisCompletedNCT00781638Not applicable
- CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative ColitisCompletedNCT00366925Not applicable
- Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)CompletedNCT00219414Phase 4
- Study for the Treatment of Ulcerative Colitis With AdacolumnCompletedNCT00102193Phase 3
- CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) RemissionCompletedNCT00092508Phase 3
- FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative ColitisCompletedNCT00064454Phase 3
- FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative ColitisCompletedNCT00064441Phase 3